Clinical Trial Update: Study of Menactra® in US Adolescents When Administered Concomitantly With Tdap Vaccine [Phase 4]

View source ↗

Summary

Phase 4 study assessing the safety of administering Menactra meningococcal vaccine concurrently with a Tdap vaccine in US adolescents; results were completed an…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Meningitis
• Meningococcemia

Drugs mentioned

• Menactra (Meningococcal conjugate vaccine (A, C, W, Y))
• Tdap vaccine (Diphtheria, tetanus, and pertussis vaccine (Tdap))

Snippet

Sponsor: Sanofi Pasteur, a Sanofi Company | Conditions: Meningitis, Meningococcemia | Phase 4 | Status: COMPLETED | Results posted: 2009-12-31